Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2024Cancer Research

Abstract PO2-15-01: EZH2 protein expression in early hormone receptor positive HER2 negative breast cancer with high recurrence score

View Full Paper
Ask AI
Bookmark
Share

Authors

SLShuwen LinYLYungtai LoDMDella Makower

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lin et al. (2024) studied this question.

synapsesocial.com/papers/68e6be91b6db64358763e4cdhttps://doi.org/10.1158/1538-7445.sabcs23-po2-15-01
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract PO4-16-01: EZH2 is Overexpressed in Invasive Carcinoma and DCIS in both BRCA1 and BRCA2 Mutation Carriers2024 · 1 citations
  2. 2Abstract PO5-01-08: The impact of Human Epidermal growth factor Receptor 2 (HER2) expression by RT-PCR on tumor characteristics and outcome in estrogen receptor (ER) positive, HER2 negative early-stage breast cancer2024
  3. 3Abstract PS3-08-11: Correlation between clinical-pathological features and recurrence score from a multigene predictive assay in hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer: a real-world, retrospective, monocentric analysis of over 700 patients2026
  4. 4Abstract PS3-09-01: Use of the OncotypeDX Recurrence Score® (RS) as a continuous prognostic biomarker in hormone receptor (HR) positive HER2neu negative early breast cancer with intermediate risk of recurrence may asses risk of recurrence or death more appropriately2026
  5. 5EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study2026